Harness brand benchmarks to guide marketing strategy throughout the product lifecycle.

Patient-Centricity 2.0 (PH222)

Adopt patient-centricity to engage end users and focus on patient needs

Pharmaceutical Commercialization Profiles (PH216)

Use Pharmaceutical Commercialization Profiles to navigate brand development and to make sure that you have the human and financial resources to ensure successful products.

Medical Device Development (PH210)

Navigate medical device development and commercialization to ensure that you have human and financial resources to ensure successful US launches.

Pharmaceutical Digital Marketing (PH196)

As regulatory and logistical barriers to digital undertakings lessen, eMarketing is growing more prevalent in pharma.  The digital space unlocks great potential for companies to expand market reach. New online channels, including social media and mobile technology, are finding their way within each company’s marketing media mix.

Promotional Speaker Programs (PH182)

Prepare promotional speaker program teams for the Sunshine Act by refocusing events on medical messages, adapting speaker bureaus, fine-tuning event management and recruiting speakers.

Pharmaceutical Mobile Health (PH174)

Explore in-depth mobile health (mHealth) data including mobile team structures, usage of mHealth initiatives, best practices and 10 mobile application case studies.

Launching Pharmaceutical Brands (PH170)

Explore detailed commercialization spending benchmarks for 15 brands to know when and how much to invest in specific areas of advertising and promotion, market access, decision support and medical affairs.

Patient Adherence and Compliance (PH166)

Develop the internal resources and strategy to engage patients, build consumer relationships and drive improved outcomes.

Pharmaceutical Marketing Strategy: Key ROI Benchmarks to Drive Brand Success (PH156)

Understand ROI benchmarks, set your marketing mix and drive brand sales.

Global Pharmaceutical Launches: Marketing Budgets and Staffing (PH62)

Prepare for drug launch by tracking budget and staffing data for 16 brands from Phase III through post-launch.

The Evolving Global Meeting Management Strategy (PH111)

Boost meeting attendance and address tough compliance issues while addressing demands from internal and external clients.

In Vitro Diagnostics: Development Through Postmarket (PH101)

Track IVDs’ commercial development with data on investment benchmarks, marketing organizations, reimbursement support and sales forces.

Pharmaceutical Customer Relationship Management: Developing and Improving CRM (PH96)

Build customer relationship management skills to manage data and communications across the organization.

Early-Stage Pharmaceutical Marketing Budgets: Preparing for Launch (PH95)

Boost your projects’ commercial potential with early spending data for 14 brands' resources from pre-clinical through Phase 2.

Post-Launch Brand Marketing in Select Affiliate Markets (PH97)

Explore brand marketing budgets in seven affiliate markets — including developed and emerging economies.

Product Director Guide to Promotional Mix (PH87)

Track 9 brands through their first three years of annual spending in advertising, promotion, market access and decision support.

Blockbuster Pharmaceutical Launches: Establishing Market Leadership (PH85)

Drive years of blockbuster returns with smart investment and strategic planning that eliminates the hurdles facing any high-profile brand.

Marketing Mid-Tier Pharmaceutical Brands: Resources for Near-Blockbusters (PH84)

Push sub-blockbuster brands as far as possible with detailed resource benchmarks from development through post-launch.

Small and Specialty Drug Branding: Tapping Niche Market Potential (PH83)

Harness resource data to support the development and launch of specialty/niche brands within global, US and European groups.

European Pharmaceutical Marketing: Launching Successful Brands (PH71)

Benchmark marketing resources from development through post-launch with brand data at the pan-European and affiliate levels.

Oncology Brand Commercialization: Resource Allocation (PH68)

Set commercialization and launch resources for oncology drugs using benchmarks for a range of critical variables.